CIP
Chartwell Investment Partners Portfolio holdings
AUM
$2.91B
1-Year Return
40.48%
This Quarter Return
+6.09%
1 Year Return
+40.48%
3 Year Return
+57.19%
5 Year Return
+149.04%
10 Year Return
+395.35%
AUM
$3.4B
AUM Growth
+$64.6M
(+1.9%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
12.61%
Holding
446
New
29
Increased
111
Reduced
237
Closed
21
Top Buys
| 1 |
AAR Corp
AIR
|
$7.02M |
| 2 |
UNVR
Univar Solutions Inc.
UNVR
|
$6.96M |
| 3 |
Huntington Bancshares
HBAN
|
$6.77M |
| 4 |
AbbVie
ABBV
|
$6.38M |
| 5 |
iShares Silver Trust
SLV
|
$6.24M |
Top Sells
| 1 |
TXNM
TXNM Energy, Inc.
TXNM
|
$12.1M |
| 2 |
Merck
MRK
|
$10.7M |
| 3 |
FOE
Ferro Corporation
FOE
|
$7.33M |
| 4 |
Lamar Advertising Co
LAMR
|
$7.17M |
| 5 |
Genuine Parts
GPC
|
$5.96M |
Sector Composition
| 1 | Technology | 18.01% |
| 2 | Financials | 17.93% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 13.15% |
| 5 | Healthcare | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Lifecore Biomedical
LFCR
$282M
| $931K | 0.03% |
82,793
-1,350
| -2% | -$15.2K |
|
|
TWNK
377
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $901K | 0.03% |
+55,675
| New | +$901K |
|
378
Baxter International
BAX
$12.5B
| $885K | 0.03% |
10,988
| – | – |
|
379
Enphase Energy
ENPH
$5.18B
| $864K | 0.03% |
4,706
| – | – |
|
380
Intellia Therapeutics
NTLA
$1.29B
| $856K | 0.03% |
+5,285
| New | +$856K |
|
381
Icon
ICLR
$13.6B
| $837K | 0.02% |
4,047
-14,264
| -78% | -$2.95M |
|
|
RDFN
382
DELISTED
Redfin
RDFN
| $820K | 0.02% |
12,932
+118
| +0.9% | +$7.48K |
|
383
Century Casinos
CNTY
$83.2M
| $806K | 0.02% |
60,049
+546
| +0.9% | +$7.33K |
|
384
Repligen
RGEN
$7.01B
| $781K | 0.02% |
3,914
| – | – |
|
385
Phathom Pharmaceuticals
PHAT
$875M
| $765K | 0.02% |
+22,589
| New | +$765K |
|
|
BHVN
386
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $762K | 0.02% |
7,852
+19
| +0.2% | +$1.84K |
|
|
CTLT
387
DELISTED
CATALENT, INC.
CTLT
| $752K | 0.02% |
6,959
| – | – |
|
388
VF Corp
VFC
$5.86B
| $750K | 0.02% |
+9,144
| New | +$750K |
|
389
Kura Oncology
KURA
$713M
| $726K | 0.02% |
34,840
+322
| +0.9% | +$6.71K |
|
390
Darling Ingredients
DAR
$5.07B
| $720K | 0.02% |
10,671
+4,328
| +68% | +$292K |
|
391
iShares Core S&P 500 ETF
IVV
$664B
| $695K | 0.02% |
1,616
| – | – |
|
392
Skyworks Solutions
SWKS
$11.2B
| $664K | 0.02% |
+3,461
| New | +$664K |
|
393
NovoCure
NVCR
$1.37B
| $657K | 0.02% |
2,963
| – | – |
|
394
Teradyne
TER
$19.1B
| $655K | 0.02% |
4,892
| – | – |
|
|
DNMR
395
DELISTED
Danimer Scientific, Inc.
DNMR
| $644K | 0.02% |
+643
| New | +$644K |
|
396
argenx
ARGX
$45.9B
| $584K | 0.02% |
1,939
| – | – |
|
|
AFMD
397
DELISTED
Affimed
AFMD
| $578K | 0.02% |
6,799
+61
| +0.9% | +$5.19K |
|
398
Allogene Therapeutics
ALLO
$255M
| $544K | 0.02% |
20,866
+188
| +0.9% | +$4.9K |
|
|
SBNY
399
DELISTED
Signature Bank
SBNY
| $536K | 0.02% |
+2,180
| New | +$536K |
|
400
Trex
TREX
$6.93B
| $533K | 0.02% |
5,222
| – | – |
|